Cerevel Therapeutics Holdings Inc

NASDAQ:CERE   3:59:53 PM EDT
25.11
+0.17 (+0.68%)
Products

Cerevel Therapeutics Announces Fast Track Designation Granted By The U.S. FDA To Cvl-871 For The Treatment Of Dementia-Related Apathy

Published: 06/15/2021 11:33 GMT
Cerevel Therapeutics Holdings Inc (CERE) - Cerevel Therapeutics Announces Fast Track Designation Granted by the U.S. FDA to Cvl-871 for the Treatment of Dementia-related Apathy.
Cerevel Therapeutics Announces Fast Track Designation Granted by the U.S. FDA to Cvl-871 for the Treatment of Dementia-related Apathy.